Jeffrey Donohue
Corporate Officer/Principal bei Novartis Institutes for Biomedical Research, Inc.
Profil
Jeffrey Donohue is currently working as a Corporate Counsel at Novartis Institutes for Biomedical Research, Inc. He previously worked as an Independent Non-Executive Director at Spectra Systems Corp.
from 2012 to 2016.
He has a graduate degree from Boston University and an undergraduate degree from Brandeis University.
Aktive Positionen von Jeffrey Donohue
| Unternehmen | Position | Beginn |
|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jeffrey Donohue
| Unternehmen | Position | Ende |
|---|---|---|
| SPECTRA SYSTEMS CORPORATION | Direktor/Vorstandsmitglied | 31.05.2016 |
Ausbildung von Jeffrey Donohue
| Boston University | Graduate Degree |
| Brandeis University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SPECTRA SYSTEMS CORPORATION | Electronic Technology |
| Private Unternehmen | 1 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
